FDA Inspection 1265169 — Murty Pharmaceuticals, Inc

Murty Pharmaceuticals, Inc — FEI 1000515343

The FDA completed an inspection of Murty Pharmaceuticals, Inc on March 28, 2025 in Lexington, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 28, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lexington, KY (United States)

Citations

IDCFRDescription
197621 CFR 211.182Specific information required in individual logs
360321 CFR 211.160(b)Scientifically sound laboratory controls